Bottom line
What is EPSRX's expense ratio?
EPSRX's expense ratio is 0.74%, or about $74 a year on every $10,000 invested. That is cheaper than 76% of global stock funds we track (median 0.95%). It has no front-end sales load.
Updated Feb 26, 2026
EPSRX fee table
| Net expense ratio | 0.74% |
|---|---|
| Gross expense ratio | 0.76% |
| Management fee | 0.7% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.06% |
| Fee waiver / reimbursement | -0.02% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 26, 2026
What EPSRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| EPSRX | $76 | $241 | $420 | $940 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.74% expense ratio costs roughly $41,900 in lost growth, versus about $52,800 for the median global stock fund (0.95%).